Close

Seattle Genetics (SGEN) 'Buy' Reiterated at Jefferies After Q1 Results and Ahead of Pipeline News

May 2, 2014 11:50 AM EDT Send to a Friend
Jefferies analyst Thomas Wei reiterated a Buy rating and $53 price target on Seattle Genetics (NASDAQ: SGEN) following Q1 results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login